Sprinklr Inc (CXM) concluded trading on Thursday at a closing price of $8.11, with 5.15 million shares of worth about $41.8 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.09% during that period and on June 12, 2025 the price saw a loss of about -5.37%. Currently the company’s common shares owned by public are about 141.85M shares, out of which, 101.04M shares are available for trading.
Stock saw a price change of -8.36% in past 5 days and over the past one month there was a price change of -4.48%. Year-to-date (YTD), CXM shares are showing a performance of -4.02% which decreased to -9.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.75 but also hit the highest price of $10.27 during that period. The average intraday trading volume for Sprinklr Inc shares is 1.81 million. The stock is currently trading -4.09% below its 20-day simple moving average (SMA20), while that difference is up 1.99% for SMA50 and it goes to -1.27% lower than SMA200.
Sprinklr Inc (NYSE: CXM) currently have 141.85M outstanding shares and institutions hold larger chunk of about 39.61% of that.
The stock has a current market capitalization of $2.10B and its 3Y-monthly beta is at 0.81. PE ratio of stock for trailing 12 months is 19.77, while it has posted earnings per share of $0.41 in the same period. Its PEG reads 1.74 and has Quick Ratio of 1.65 while making debt-to-equity ratio of 0.08. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CXM, volatility over the week remained 3.01% while standing at 2.69% over the month.
Stock’s fiscal year EPS is expected to rise by 13.97% while it is estimated to increase by 9.19% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on June 03, 2025 offering a Neutral rating for the stock and assigned a target price of $8 to it. On December 11, 2024, JP Morgan Downgrade their recommendations, while on November 19, 2024, Scotiabank Initiated their ratings for the stock with a price target of $7.70. Stock get an Underweight rating from Wells Fargo on November 12, 2024.
